IHE icon

iShares US Pharmaceuticals ETF

91 hedge funds and large institutions have $205M invested in iShares US Pharmaceuticals ETF in 2016 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 47 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding:

less funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

less capital invested

Capital invested by funds: $ → $

52% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 23

72% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 47

Holders
91
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$7.43M
2 +$5.01M
3 +$3.64M
4
CS
Credit Suisse
Switzerland
+$3.09M
5
VKH
Virtu KCG Holdings
New York
+$2.25M

Top Sellers

1 -$21.6M
2 -$20.5M
3 -$11M
4
Bank of America
Bank of America
North Carolina
-$10.1M
5
LPL Financial
LPL Financial
California
-$7.53M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$22.4M
2
$19.5M
3
$14M
4
$13.8M
5
$11.9M
6
$11.5M
7
$10.9M
8
$9.55M
9
$9.39M
10
$7.43M
11
$7.14M
12
$5.42M
13
$5.38M
14
$4.95M
15
$3.72M
16
$3.64M
17
$3.58M
18
$3.45M
19
$2.45M
20
$2.25M
21
$1.86M
22
$1.83M
23
$1.59M
24
$1.58M
25
$1.34M